Showing results (151-160 of 980) with videos related to
Sort By:
Pageof 98
Cardiovascular Therapeutics|October 27, 2010
Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunctionNan Jia, Peixin Dong, Ying Ye, et al.Cardiovascular Therapeutics|March 16, 2013
Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunctionZhi-Qiang Hou, Zhao-Xia Sun, Chong-Yi Su, et al.Cardiovascular Therapeutics|February 16, 2013
Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)Masa-Aki Kawashiri, Masakazu Yamagishi, Tomohiro Sakamoto, et al.Cardiovascular Therapeutics|May 3, 2013
Factor Xa inhibitor attenuates leukocyte adhesion and thrombus formation in an experimental mouse model of the metabolic syndromeToshiaki Iba, Koichiro Aihara, Shin Watanabe, et al.Cardiovascular Therapeutics|May 3, 2013
The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delayYa-Ling Han, Jian-Ning Liu, Quan-Min Jing, et al.Cardiovascular Therapeutics|January 4, 2012
Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cellsWojciech Pepke, Andreas Eisenreich, Markus Jaster, et al.Cardiovascular Therapeutics|October 15, 2013
Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case seriesFrancesco Santoro, Riccardo Ieva, Armando Ferraretti, et al.Cardiovascular Therapeutics|October 15, 2013
Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosisZohara Sternberg, Christopher Leung, Daniel Sternberg, et al.Cardiovascular Therapeutics|October 11, 2013
The effect of SN-6, a novel sodium-calcium exchange inhibitor, on contractility and calcium handling in isolated failing rat ventricular myocytesAjay Gandhi, Urszula Siedlecka, Adarsh P Shah, et al.Cardiovascular Therapeutics|May 21, 2013
Propafenone versus vernakalant for conversion of recent-onset atrial fibrillationDiego Conde, Juan Pablo Costabel, Martin Aragon, et al.Pageof 98